PharmacoEconomics German Research Articles最新文献

筛选
英文 中文
Der Analytic Hierarchy Process (AHP): Eine Methode zur Entscheidungsunterstützung im Gesundheitswesen 研究支持新疗法
PharmacoEconomics German Research Articles Pub Date : 2013-10-01 DOI: 10.1007/S40275-014-0011-8
A. Mühlbacher, A. Kaczynski
{"title":"Der Analytic Hierarchy Process (AHP): Eine Methode zur Entscheidungsunterstützung im Gesundheitswesen","authors":"A. Mühlbacher, A. Kaczynski","doi":"10.1007/S40275-014-0011-8","DOIUrl":"https://doi.org/10.1007/S40275-014-0011-8","url":null,"abstract":"","PeriodicalId":445671,"journal":{"name":"PharmacoEconomics German Research Articles","volume":"17 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2013-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122361364","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 23
Ist ein neues Arzneimittel sein Geld wert? Wessen Geld? – Bewertung eines neuen Diabetes-Präparats mit Hilfe eines Discrete-Choice-Experiments 新药价钱公道吗?谁的钱?…使用随地选择实验评估某人的新糖尿病标本
PharmacoEconomics German Research Articles Pub Date : 2013-10-01 DOI: 10.1007/S40275-014-0010-9
Michele Sennhauser, P. Zweifel
{"title":"Ist ein neues Arzneimittel sein Geld wert? Wessen Geld? – Bewertung eines neuen Diabetes-Präparats mit Hilfe eines Discrete-Choice-Experiments","authors":"Michele Sennhauser, P. Zweifel","doi":"10.1007/S40275-014-0010-9","DOIUrl":"https://doi.org/10.1007/S40275-014-0010-9","url":null,"abstract":"","PeriodicalId":445671,"journal":{"name":"PharmacoEconomics German Research Articles","volume":"93 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2013-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115121366","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Eine vergleichende Kostenanalyse von sechs Anticholinergika zur Behandlung der überaktiven Blase und Inkontinenz in Deutschland 她对6项抗毒剂的成本分析进行了比较分析,这些都是用来治疗德国过度活跃的泡沫和失禁
PharmacoEconomics German Research Articles Pub Date : 2013-10-01 DOI: 10.1007/S40275-014-0005-6
S. Felder, Thomas Mayrhofer
{"title":"Eine vergleichende Kostenanalyse von sechs Anticholinergika zur Behandlung der überaktiven Blase und Inkontinenz in Deutschland","authors":"S. Felder, Thomas Mayrhofer","doi":"10.1007/S40275-014-0005-6","DOIUrl":"https://doi.org/10.1007/S40275-014-0005-6","url":null,"abstract":"","PeriodicalId":445671,"journal":{"name":"PharmacoEconomics German Research Articles","volume":"16 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2013-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131310279","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prioritäten bei der Therapie des Multiplen Myeloms: Eine Analyse der Perspektive von Ärzten 化疗的首要治疗:分析医生的观点
PharmacoEconomics German Research Articles Pub Date : 2013-10-01 DOI: 10.1007/S40275-014-0008-3
A. Mühlbacher, M. Nübling
{"title":"Prioritäten bei der Therapie des Multiplen Myeloms: Eine Analyse der Perspektive von Ärzten","authors":"A. Mühlbacher, M. Nübling","doi":"10.1007/S40275-014-0008-3","DOIUrl":"https://doi.org/10.1007/S40275-014-0008-3","url":null,"abstract":"","PeriodicalId":445671,"journal":{"name":"PharmacoEconomics German Research Articles","volume":"52 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2013-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133762183","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Experimentelle Präferenzmessung im Gesundheitswesen mit Hilfe von Best-Worst Scaling (BWS) 用最有效的辅助疗法对医疗事业进行实验性偏好测试
PharmacoEconomics German Research Articles Pub Date : 2013-10-01 DOI: 10.1007/S40275-014-0012-7
A. Mühlbacher, A. Kaczynski, P. Zweifel
{"title":"Experimentelle Präferenzmessung im Gesundheitswesen mit Hilfe von Best-Worst Scaling (BWS)","authors":"A. Mühlbacher, A. Kaczynski, P. Zweifel","doi":"10.1007/S40275-014-0012-7","DOIUrl":"https://doi.org/10.1007/S40275-014-0012-7","url":null,"abstract":"","PeriodicalId":445671,"journal":{"name":"PharmacoEconomics German Research Articles","volume":"51 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2013-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130382671","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Allokation medizinischer Ressourcen – Eine Übersicht experimenteller Ergebnisse zur Akzeptanz von Verteilungsregeln 就是关于如何接受分配规则的试验结果
PharmacoEconomics German Research Articles Pub Date : 2013-10-01 DOI: 10.1007/S40275-014-0009-2
Marlies Ahlert, L. Schwettmann
{"title":"Allokation medizinischer Ressourcen – Eine Übersicht experimenteller Ergebnisse zur Akzeptanz von Verteilungsregeln","authors":"Marlies Ahlert, L. Schwettmann","doi":"10.1007/S40275-014-0009-2","DOIUrl":"https://doi.org/10.1007/S40275-014-0009-2","url":null,"abstract":"","PeriodicalId":445671,"journal":{"name":"PharmacoEconomics German Research Articles","volume":"3 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2013-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125221047","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
AMNOG – Erste Erfahrungen und mögliche Auswirkungen auf die Klinische Forschung 对临床研究的最初经验和潜在影响的研究
PharmacoEconomics German Research Articles Pub Date : 2013-08-14 DOI: 10.1007/S40275-013-0002-1
Maike Bestehorn, R. Tunder
{"title":"AMNOG – Erste Erfahrungen und mögliche Auswirkungen auf die Klinische Forschung","authors":"Maike Bestehorn, R. Tunder","doi":"10.1007/S40275-013-0002-1","DOIUrl":"https://doi.org/10.1007/S40275-013-0002-1","url":null,"abstract":"","PeriodicalId":445671,"journal":{"name":"PharmacoEconomics German Research Articles","volume":"24 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2013-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125958538","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Drei Jahre frühe Nutzenbewertung nach §35a SGB V – kritische Würdigung und Lösungsvorschlag 后三年早期Nutzenbewertung§35a SGB V -批判性赞扬和提案
PharmacoEconomics German Research Articles Pub Date : 2013-04-01 DOI: 10.1007/S40275-014-0007-4
Susanne Höhle-Pasques, J. Hankowitz, P. Oberender
{"title":"Drei Jahre frühe Nutzenbewertung nach §35a SGB V – kritische Würdigung und Lösungsvorschlag","authors":"Susanne Höhle-Pasques, J. Hankowitz, P. Oberender","doi":"10.1007/S40275-014-0007-4","DOIUrl":"https://doi.org/10.1007/S40275-014-0007-4","url":null,"abstract":"","PeriodicalId":445671,"journal":{"name":"PharmacoEconomics German Research Articles","volume":"16 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2013-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127630232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Kosteneffektivität von Apixaban zur Verhinderung von Schlaganfällen bei Vorhofflimmern in Deutschland 阿匹克斯本以成本效率为基础,在德国防止中风
PharmacoEconomics German Research Articles Pub Date : 2013-04-01 DOI: 10.1007/S40275-014-0006-5
A. Reimer, O. Schöffski
{"title":"Kosteneffektivität von Apixaban zur Verhinderung von Schlaganfällen bei Vorhofflimmern in Deutschland","authors":"A. Reimer, O. Schöffski","doi":"10.1007/S40275-014-0006-5","DOIUrl":"https://doi.org/10.1007/S40275-014-0006-5","url":null,"abstract":"","PeriodicalId":445671,"journal":{"name":"PharmacoEconomics German Research Articles","volume":"6 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2013-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126677476","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Budget Impact Analyse von Paliperidon Palmitat im österreichischen Versorgungskontext 项目开支影响分析
PharmacoEconomics German Research Articles Pub Date : 2013-04-01 DOI: 10.1007/S40275-013-0003-0
S. Ransmayr, A. Mehnert, J. Mahlich
{"title":"Budget Impact Analyse von Paliperidon Palmitat im österreichischen Versorgungskontext","authors":"S. Ransmayr, A. Mehnert, J. Mahlich","doi":"10.1007/S40275-013-0003-0","DOIUrl":"https://doi.org/10.1007/S40275-013-0003-0","url":null,"abstract":"","PeriodicalId":445671,"journal":{"name":"PharmacoEconomics German Research Articles","volume":"13 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2013-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132763608","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书